CDX2 and bladder adenocarcinoma: A significant number of PBA cases (one-third) and MCA cases (8.3%) exhibited strong CK7 expression, suggesting a limited ability to distinguish PBAs from secondary bladder adenocarcinomas based on CK7 and CDX-2.